Ropes Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $2.39M | Sell |
5,474
-1,646
| -23% | -$821K | 0.46% | 52 |
|
|
2023
Q2 | $3.58M | Sell |
7,120
-15
| -0.2% | -$7.19K | 0.59% | 42 |
|
|
2023
Q1 | $3.57M | Sell |
7,135
-161
| -2% | -$77K | 0.65% | 40 |
|
|
2022
Q4 | $2.98M | Sell |
7,296
-84
| -1% | -$32.6K | 0.53% | 43 |
|
|
2022
Q3 | $2.4M | Sell |
7,380
-15
| -0.2% | -$5.51K | 0.51% | 51 |
|
|
2022
Q2 | $2.59M | Sell |
7,395
-25
| -0.3% | -$10.2K | 0.53% | 47 |
|
|
2022
Q1 | $4.06M | Sell |
7,420
-50
| -0.7% | -$26.3K | 0.7% | 33 |
|
|
2021
Q4 | $4.92M | Sell |
7,470
-367
| -5% | -$230K | 0.87% | 29 |
|
|
2021
Q3 | $4.87M | Buy |
7,837
+63
| +0.8% | +$42.3K | 0.78% | 31 |
|
|
2021
Q2 | $4.91M | Buy |
7,774
+47
| +0.6% | +$26K | 0.78% | 33 |
|
|
2021
Q1 | $4.08M | Buy |
7,727
+160
| +2% | +$80.2K | 0.72% | 38 |
|
|
2020
Q4 | $3.78M | Sell |
7,567
-170
| -2% | -$76.1K | 0.59% | 35 |
|
|
2020
Q3 | $3.04M | Hold |
7,737
| – | – | 0.59% | 37 |
|
|
2020
Q2 | $2.55M | Sell |
7,737
-405
| -5% | -$117K | 0.52% | 41 |
|
|
2020
Q1 | $1.97M | Hold |
8,142
| – | – | 0.5% | 46 |
|
|
2019
Q4 | $2.13M | Buy |
8,142
+730
| +10% | +$192K | 0.46% | 51 |
|
|
2019
Q3 | $2.02M | Buy |
7,412
+119
| +2% | +$33.1K | 0.43% | 53 |
|
|
2019
Q2 | $2.01M | Buy |
7,293
+38
| +0.5% | +$9.36K | 0.42% | 52 |
|
|
2019
Q1 | $1.62M | Buy |
7,255
+2,150
| +42% | +$444K | 0.43% | 56 |
|
|
2018
Q4 | $950K | Sell |
5,105
-175
| -3% | -$35.9K | 0.27% | 83 |
|
|
2018
Q3 | $1.32M | Sell |
5,280
-552
| -9% | -$134K | 0.33% | 77 |
|
|
2018
Q2 | $1.27M | Buy |
5,832
+952
| +20% | +$196K | 0.34% | 68 |
|
|
2018
Q1 | $934K | Hold |
4,880
| – | – | 0.26% | 97 |
|
|
2017
Q4 | $763K | Hold |
4,880
| – | – | 0.2% | 112 |
|
|
2017
Q3 | $759K | Sell |
4,880
-160
| -3% | -$25.3K | 0.21% | 102 |
|
|
2017
Q2 | $814K | Buy |
5,040
+200
| +4% | +$32.5K | 0.23% | 97 |
|
|
2017
Q1 | $748K | Hold |
4,840
| – | – | 0.22% | 100 |
|
|
2016
Q4 | $568K | Hold |
4,840
| – | – | 0.18% | 112 |
|
|
2016
Q3 | $546K | Hold |
4,840
| – | – | 0.18% | 108 |
|
|
2016
Q2 | $449K | Hold |
4,840
| – | – | 0.16% | 114 |
|
|
2016
Q1 | $379K | Hold |
4,840
| – | – | 0.17% | 102 |
|
|
2015
Q4 | $353K | Hold |
4,840
| – | – | 0.16% | 110 |
|
|
2015
Q3 | $359K | Hold |
4,840
| – | – | 0.19% | 90 |
|
|
2015
Q2 | $310K | Hold |
4,840
| – | – | 0.17% | 101 |
|
|
2015
Q1 | $374K | Buy |
+4,840
| New | +$377K | 0.19% | 92 |
|
Other funds holding IDXX
Ropes Wealth Advisors's IDXX Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 23% in Q3 2023, selling an estimated $821K and leaving 5,474 shares worth $2.39M. The position accounts for 0.46% of the portfolio, ranked #52.
Ropes Wealth Advisors first reported a position in IDXX in Q1 2015 and has held it in 35 quarters since. The position peaked at $4.92M in Q4 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.
- Ropes Wealth Advisors held 5,474 shares of Idexx Laboratories worth $2.39M as of Q3 2023.
- Ropes Wealth Advisors sold 1,646 Idexx Laboratories shares in Q3 2023, an estimated $821K.
- Idexx Laboratories made up 0.46% of Ropes Wealth Advisors's portfolio in Q3 2023, its #52 holding.
- Ropes Wealth Advisors first reported a position in Idexx Laboratories in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's Idexx Laboratories position peaked at $4.92M in Q4 2021.
- 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.